Description
Tecentriq (atezolizumab) is a prescription monoclonal antibody made by Genentech, Inc., given intravenously to treat certain cancers. It works by blocking PD-1 receptors to help the immune system fight tumors. Available as a 1200 mg/20 mL solution in single-use vials. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the FDA dataset for Atezolizumab — ANDA 761347 submitted by Mylan Institutional LLC
|
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761347 |
Tags
- health-care
- drug-manufacturers
- public-health
- prescription-drugs
- pharmaceuticals